Sickert Denise, Kroeger Kerstin, Zickler Christophe, Chokote Edwige, Winkler Barbara, Grenet Jean-Michel, Legay Francois, Zaar Annette
Novartis Pharma AG, Postfach, CH-4002, Basel, Switzerland.
J Immunol Methods. 2008 May 20;334(1-2):29-36. doi: 10.1016/j.jim.2008.01.010. Epub 2008 Feb 14.
Detection of anti-drug antibodies (ADA) can be difficult, if not impossible, in the presence of drug in the sample. This is a particular concern with therapeutic monoclonal antibodies (mAbs), which have typically longer half-lives than other proteins. For detection of ADA in presence of high drug concentrations, assay choice is limited to ELISA-like methods, capable of incorporating acid dissociation procedures to separate drug-ADA immune complexes. To our knowledge, Biacore assays have not been shown to be directly compatible with acid dissociation procedures, until now. As a consequence, steps to ensure adequate clearance of the drug are prerequisite to enable sensitive detection of ADA. Here we describe the development of a novel, rapid and highly drug tolerant Biacore method that uses an acid dissociation step to detect ADA in the presence of excess drug in human serum. Removal of drug after acid treatment is not required.
在样本中存在药物的情况下,检测抗药物抗体(ADA)即便并非完全不可能,也可能会很困难。对于治疗性单克隆抗体(mAb)而言,这是一个特别需要关注的问题,因为它们的半衰期通常比其他蛋白质更长。为了在高药物浓度下检测ADA,检测方法的选择仅限于类似酶联免疫吸附测定(ELISA)的方法,这类方法能够采用酸解离程序来分离药物 - ADA免疫复合物。据我们所知,直到现在,表面等离子体共振(Biacore)检测方法尚未被证明能直接与酸解离程序兼容。因此,确保药物充分清除的步骤是实现ADA灵敏检测的先决条件。在此,我们描述了一种新型、快速且高度耐药物的Biacore方法的开发,该方法使用酸解离步骤在人血清中存在过量药物的情况下检测ADA。酸处理后无需去除药物。